Delphinus Medical Technologies, based in Sunnyvale, CA, is a leading provider of innovative medical imaging solutions for healthcare professionals. Their flagship product, the SoftVue 3D Whole Breast Ultrasound Tomography system, is FDA PMA approved specifically for dense breast screening, offering a breakthrough approach to breast cancer detection that enhances sensitivity and specificity compared to mammography alone.
With over 2,000 transducer elements and TriAD triple acoustic detection, SoftVue delivers reflection imaging for tissue structure and captures transmission signals passing through the breast, providing physicians with an unrivaled view of breast tissue structure and attributes. This transformative technology has the potential to significantly improve the diagnosis of breast cancer in women with dense breasts, who are at a higher risk of developing the disease.
Generated from the website